Existing investor Sinopharm Capital came back for a $57.7m round that will support the progression of the small-molecule drug developer's pipeline.

Blue Cloud Ventures and Stereo Capital co-led a series D round for the Sonae-backed cybersecurity services provider, pushing its total funding past the $150m mark.

CapitalG co-led a series C round for Everlaw, developer of a legal information search product, which has now secured more than $96m in total.

Bristol-Meyers Squibb participated in the $78.5m round, which will be used to push Silverback Therapeutics' lead cancer drug candidate towards clinical trials.

The Marcus & Millichap and Axel Springer-backed rental real estate portal has completed its series D round to bring its overall equity funding to more than $150m.

Meituan Dianping led a round for the agricultural distribution services provider that also featured existing backer Hidden Hill.

Bio-fungicide and pesticide developer Biotalys has added $11.3m to a Globalchem-backed round now totalling $50.9m.

ABB Technology Ventures and NEC took part in a $60m series B round that will support the AI processor developer’s global expansion efforts.

Biotalys, a bio-fungicide and pesticide developer based on VIB technology previously known as AgroSavfe, has added $11m to its series C round.

The app development software provider increased its overall funding to more than $97m in a series C round that did not include existing corporate investor Bloomberg Beta.